Share this post on:

Product Name :
Trimethoprim/Sulfaguanidine

Search keywords :
Trimethoprim

drugId :
null

Target Vo:
Dihydrofolate reductase

Target Vo Short Name :
DHFR

Moa_Name:
Dihydrofolate reductase inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
1994

Origin Company_Name :
Jilin Shangcheng Pharmaceutical CO LTD

Active Company_Name :
Changchun Xin’An Pharmaceutical Inc

Active Indication_Name:
Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CaMKII alpha Rabbit mAb Purity
Fibronectin Rabbit mAb Technical Information
RUNX Antibody: RUNX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 49 kDa, targeting to RUNX. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related